Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deepika Jalota Insider Profile
4 Followers
Deepika Jalota, CDO at PMV Pharmaceuticals, holds 118.28K shares in PMV Pharmaceuticals (Ticker: PMVP). Most recently, Deepika Jalota Sold $7,218 shares of PMV Pharmaceuticals on Sep 12, 2024 for an estimated value of 10.83K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+29.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CDO
Roles that Deepika Jalota holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 18, 2023 - Sep 18, 2024
Return:+75.60%
The most profitable trade made by Deepika Jalota
Deepika Jalota's Trading History
List of latest transactions for each holding click on a transaction to see Deepika Jalota's performance on stock
You May Also Like
Deepika Jalota insider profile FAQ
What is the percentage of profitable transactions made by Deepika Jalota?
The percentage of profitable transactions made by Deepika Jalota is 50%.
What is the average return per transaction made by Deepika Jalota?
The average return per transaction made by Deepika Jalota is 29.40%.
What stocks does Deepika Jalota hold?
Deepika Jalota holds: PMVP stocks.
What was Deepika Jalota’s latest transaction?
Deepika Jalota latest transaction was an Informative Sell of $10.83K.
What was Deepika Jalota's most profitable transaction?
Deepika Jalota’s most profitable transaction was an Informative Sell of PMVP stock on September 18, 2023. The return on the trade was 75.60%.
What is Deepika Jalota's role in PMV Pharmaceuticals?
Deepika Jalota's role in PMV Pharmaceuticals is CDO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.